BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3994127)

  • 1. Demonstration of vaccine-induced immunity to anaplasmosis without induction of persistent postvaccinal complement-fixing and agglutinating antibodies in yearling steers.
    Corrier DE; Johnson JS; Wagner GG
    Am J Vet Res; 1985 Mar; 46(3):583-6. PubMed ID: 3994127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and use of a modified live Anaplasma marginale vaccine in beef heifers in California.
    Henry ET; Norman BB; Fly DE; Wichmann RW; York SM
    J Am Vet Med Assoc; 1983 Jul; 183(1):66-9. PubMed ID: 6874525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates.
    Kuttler KL; Zaugg JL; Johnson LW
    Am J Vet Res; 1984 Nov; 45(11):2223-6. PubMed ID: 6084430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection.
    Abdala AA; Pipano E; Aguirre DH; Gaido AB; Zurbriggen MA; Mangold AJ; Guglielmone AA
    Rev Elev Med Vet Pays Trop; 1990; 43(2):155-8. PubMed ID: 2092348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplasma marginale field challenge: protection by an inactivated immunogen that shares partial sequence of msp1alpha variable region with the challenge strain.
    Vega LE; Rodríguez SD; Alarcón GJ; Flores RL; Ocampo RJ; Ortiz MA; de la Torre JF; Ramírez EE
    Vaccine; 2007 Jan; 25(3):519-25. PubMed ID: 17049686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of an attenuated Anaplasma marginale vaccine in Mexico natural challenge of immunity in an enzootic area.
    Osorno MB; Solana PM; Perez JM; Lopez TR
    Am J Vet Res; 1975 May; 36(5):631-3. PubMed ID: 1137209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity related to challenge exposure of cattle inoculated with virulent and attenuated strains of Anaplasma marginale.
    Carson CA; Sells DM; Ristic M
    Am J Vet Res; 1977 Aug; 38(8):1167-72. PubMed ID: 911085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the complement fixation test and competitive ELISA for serodiagnosis of Anaplasma marginale infection in experimentally infected steers.
    Coetzee JF; Schmidt PL; Apley MD; Reinbold JB; Kocan KM
    Am J Vet Res; 2007 Aug; 68(8):872-8. PubMed ID: 17669027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale.
    Lincoln SD; Zaugg JL; Maas J
    J Am Vet Med Assoc; 1987 Jan; 190(2):171-3. PubMed ID: 3818429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplasma marginale infections in American bison: experimental infection and serologic study.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1985 Feb; 46(2):438-41. PubMed ID: 3994109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.
    de la Fuente J; Kocan KM; Garcia-Garcia JC; Blouin EF; Claypool PL; Saliki JT
    Vet Microbiol; 2002 Oct; 89(2-3):239-251. PubMed ID: 12243900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative titration of Anaplasma marginale antibodies by card agglutination and complement-fixation tests.
    Amerault TE; Rose JE; Kuttler KL
    Am J Vet Res; 1981 Jun; 42(6):1055-6. PubMed ID: 7283236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses of cows to a chemically modified anaplasma antigen.
    Buening GM
    Am J Vet Res; 1978 Jun; 39(6):925-30. PubMed ID: 666088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Card agglutination and complement-fixation reactions after vaccination of cattle against anaplasmosis.
    Amerault TE; Roby TO
    J Am Vet Med Assoc; 1971 Dec; 159(12):1749-51. PubMed ID: 5128789
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination with Anaplasma centrale: response after an experimental challenge with Anaplasma marginale.
    Anziani OS; Tarabla HD; Ford CA; Galleto C
    Trop Anim Health Prod; 1987 May; 19(2):83-7. PubMed ID: 3629722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of immune responses of cattle to erythrocyte stroma, Anaplasma antigen, and dodecanoic acid-conjugated Anaplasma antigen: cell-mediated immunity.
    Francis DH; Buening GM; Amerault TE
    Am J Vet Res; 1980 Mar; 41(3):368-71. PubMed ID: 7369609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell culture-derived Babesia bovis vaccine: sequential challenge exposure of protective immunity during a 6-month postvaccination period.
    Kuttler KL; Levy MG; Ristic M
    Am J Vet Res; 1983 Aug; 44(8):1456-9. PubMed ID: 6354014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an indirect fluorescent antibody test, using microfluorometry as a diagnostic test for bovine anaplasmosis.
    Goff WL; Johnson WC; Kuttler KL
    Am J Vet Res; 1985 May; 46(5):1080-4. PubMed ID: 3890629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.